Cite
HARVARD Citation
Dinneen, E. et al. (2022). Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. BJUI Compass. 3 (6), pp. 458-465. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dinneen, E. et al. (2022). Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. BJUI Compass. 3 (6), pp. 458-465. [Online].